KDM2A Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2803-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

KDM2A, a JmjC domain-containing histone demethylase, plays a critical role in regulating chromatin structure and gene expression by specifically demethylating H3K36me2 and H3K36me1. Its structure includes a JmjC catalytic domain, a CXXC zinc finger that binds unmethylated CpG islands, a PHD domain, and an F-box that facilitates recruitment to the SCF ubiquitin ligase complex.

Reported cellular context includes chromosome and nucleus, which can matter when signal is compared across treatments or changing cell states. Following KDM2A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

KDM2A is commonly interpreted in the context of cancer and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between chromosome and nucleus across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • links between target behavior and transcriptional or chromatin-state changes
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for KDM2A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in KDM2A reflect biology rather than handling. When interpreting KDM2A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep KDM2A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
KDM2A
Research Area:
Cancer • Epigenetics
Application:
IF • IHC • IP • WB
Reactivity:
Human • Mouse • Rat
Specificity:
KDM2A Antibody [B7P10] recognizes endogenous levels of total KDM2A protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
B7P10
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.